Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.

@article{Nelson2018PredictorsOT,
  title={Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.},
  author={David B. Nelson and David Rice and Jiangong Niu and Scott Michael Atay and Ara Asadur Vaporciyan and Mara B. Antonoff and Wayne Lewis Hofstetter and Garrett L. Walsh and Stephen G. Swisher and J. L. A. Roth and Anne S. Tsao and Daniel Richard Gomez and Sharon Hermes Giordano and Reza John Mehran and Boris Sepesi},
  journal={European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery},
  year={2018},
  volume={53 5},
  pages={960-966}
}
OBJECTIVES Malignant pleural mesothelioma is an aggressive and rare malignancy that frequently recurs despite aggressive therapy. We evaluated the frequency of treatment with surgery, radiation or chemotherapy, changes in therapy and survival over time and factors associated with the receipt of trimodality therapy. METHODS The National Cancer Database… CONTINUE READING